These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Influence of bupropion HCl (Wellbatrin), a novel antidepressant, on plasma levels of prolactin and growth hormone in man and rat. Stern WC; Rogers J; Fang V; Meltzer H Life Sci; 1979 Nov; 25(20):1717-24. PubMed ID: 316848 [No Abstract] [Full Text] [Related]
9. The use of bupropion in hospitalized depressed patients. Merideth CH; Feighner JP J Clin Psychiatry; 1983 May; 44(5 Pt 2):85-7. PubMed ID: 6406471 [TBL] [Abstract][Full Text] [Related]
10. Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers. Elman I; Lukas SE Addict Behav; 2005 May; 30(4):859-64. PubMed ID: 15833589 [TBL] [Abstract][Full Text] [Related]
11. Two multicenter studies of the antidepressant effects of bupropion HCl versus placebo. Stern WC; Harto-Truax N Psychopharmacol Bull; 1980 Jul; 16(3):43-6. PubMed ID: 6773096 [No Abstract] [Full Text] [Related]
13. Assessing the effects of bupropion SR on mood dimensions of depression. Tomarken AJ; Dichter GS; Freid C; Addington S; Shelton RC J Affect Disord; 2004 Mar; 78(3):235-41. PubMed ID: 15013248 [TBL] [Abstract][Full Text] [Related]
14. The effect of bupropion, a new antidepressant drug, and alcohol and their interaction in man. Hamilton MJ; Bush MS; Peck AW Eur J Clin Pharmacol; 1984; 27(1):75-80. PubMed ID: 6436033 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers. Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa. Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795 [TBL] [Abstract][Full Text] [Related]
17. Determination of plasma bupropion and its relationship to therapeutic effect. Fogel P; Mamer OA; Chouinard G; Farrell PG Biomed Mass Spectrom; 1984 Dec; 11(12):629-32. PubMed ID: 6442168 [TBL] [Abstract][Full Text] [Related]
18. A case of bupropion-associated delirium. Dager SR; Heritch AJ J Clin Psychiatry; 1990 Jul; 51(7):307-8. PubMed ID: 2114399 [TBL] [Abstract][Full Text] [Related]
19. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man. Ur E; Wright DM; Bouloux PM; Grossman A Br J Pharmacol; 1997 Mar; 120(5):781-4. PubMed ID: 9138682 [TBL] [Abstract][Full Text] [Related]
20. Clinical profile of the novel antidepressant bupropion. Stern WC; Harto-Truax N; Rogers J; Miller L Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060 [No Abstract] [Full Text] [Related] [Next] [New Search]